SEC Form 4 · accession 0001225208-15-021322
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martha H. Marsh
Director
Period of report
Nov 19, 2015
Accepted (ET)
Nov 23, 2015 · 7:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Acquire)F1 | $155.93 | Nov 19, 2015 | A | 4,787 | A | Nov 19, 2016 | Nov 18, 2022 | Common Stock | 4,787 | 4,787 | D |
Explanation of responses
- F1This option was granted on November 19, 2015 under the Edwards Lifesciences Corporation Nonemployee Directors Stock Incentive Program and becomes exercisable as follows: 1,595 on November 19, 2016, 1,596 on November 19, 2017, and 1,596 on November 19, 2018.